• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物相关性房室传导阻滞患者在首次住院期间无需永久起搏器的长期随访

Long-term follow-up of patients with drug-related atrioventricular block without a need of permanent pacemaker during index hospitalization.

作者信息

Parsova Kemal Emrecan, Hayiroglu Mert Ilker, Pay Levent, Cinier Goksel, Gurkan Kadir

机构信息

Department of Cardiology, Zile State Hospital, Tokat, Turkey.

Department of Cardiology, University of Health Sciences, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Selimiye Mahallesi, Tıbbiye Caddesi, No: 13, Uskudar, 34668, Istanbul, Turkey.

出版信息

Egypt Heart J. 2022 Aug 1;74(1):56. doi: 10.1186/s43044-022-00297-3.

DOI:10.1186/s43044-022-00297-3
PMID:35913636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9343480/
Abstract

BACKGROUND

Most of the patients hospitalized due to drug-related atrioventricular (AV) block do not require permanent pacemaker implantation (PPI) since AV block regresses following cessation of the responsible drug. However, AV block requiring PPI may relapse in long-term follow-up. In this study, we retrospectively evaluated the factors predicting the need for a PPI in the long-term follow-up in patients admitted to our hospital with drug-related AV block but did not require PPI in index hospitalization.

RESULTS

We evaluated 177 patients who had been hospitalized with drug-related AV block between January 2012 and July 2020 and who had not required PPI during hospital follow-up. The patients were divided into two groups according to whether PPI was performed or not. The independent predictors of long-term PPI were evaluated and the effect of glomerular filtration rate (GFR) of the patients during the index hospitalization on the long-term outcome was compared. A GFR above 60 ml/min is an independent significant risk factor in predicting long-term permanent pacemaker implantation in drug-related AV blocks. It is found that the need for PPI was 2.64 times higher without adjusted and 1.9 times higher with adjusted for all covariates in patients with GFR above 60 ml/min during hospitalization compared to those with GFR below 30 ml/min.

CONCLUSIONS

GFR may be considered as an indicator of the PPI need in patients with drug-related atrioventricular AV block.

摘要

背景

大多数因药物相关的房室传导阻滞住院的患者,在停用相关药物后房室传导阻滞消退,无需植入永久性起搏器(PPI)。然而,需要PPI的房室传导阻滞在长期随访中可能会复发。在本研究中,我们回顾性评估了我院因药物相关房室传导阻滞住院但在首次住院时无需PPI的患者在长期随访中预测PPI需求的因素。

结果

我们评估了2012年1月至2020年7月期间因药物相关房室传导阻滞住院且在住院随访期间无需PPI的177例患者。根据是否进行PPI将患者分为两组。评估长期PPI的独立预测因素,并比较患者在首次住院期间的肾小球滤过率(GFR)对长期结局的影响。GFR高于60 ml/min是预测药物相关房室传导阻滞长期植入永久性起搏器的独立显著危险因素。结果发现,住院期间GFR高于60 ml/min的患者与GFR低于30 ml/min的患者相比,未调整时PPI需求高2.64倍,调整所有协变量后高1.9倍。

结论

GFR可被视为药物相关房室传导阻滞患者PPI需求的一个指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0f5/9343480/847a537d69f1/43044_2022_297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0f5/9343480/847a537d69f1/43044_2022_297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0f5/9343480/847a537d69f1/43044_2022_297_Fig1_HTML.jpg

相似文献

1
Long-term follow-up of patients with drug-related atrioventricular block without a need of permanent pacemaker during index hospitalization.药物相关性房室传导阻滞患者在首次住院期间无需永久起搏器的长期随访
Egypt Heart J. 2022 Aug 1;74(1):56. doi: 10.1186/s43044-022-00297-3.
2
The need for permanent pacemaker after restoration of conduction following atrioventricular block: a retrospective cohort study.
Turk Kardiyol Dern Ars. 2020 Mar;48(2):103-108. doi: 10.5543/tkda.2019.96613.
3
Complete atrioventricular block after isolated aortic valve replacement.单纯主动脉瓣置换术后发生完全性房室传导阻滞。
Kardiol Pol. 2016;74(9):985-93. doi: 10.5603/KP.a2016.0038. Epub 2016 Apr 4.
4
Management and outcome of topical beta-blocker-induced atrioventricular block.局部应用β受体阻滞剂所致房室传导阻滞的管理与转归
Cardiovasc J Afr. 2015 Nov-Dec;26(6):210-3. doi: 10.5830/CVJA-2015-030.
5
Severe conduction defects requiring permanent pacemaker implantation in patients with a new-onset left bundle branch block after transcatheter aortic valve implantation.经导管主动脉瓣植入术后新发左束支传导阻滞患者中需要永久性起搏器植入的严重传导缺陷。
Europace. 2017 Jun 1;19(6):1015-1021. doi: 10.1093/europace/euw174.
6
Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System.经导管主动脉瓣植入术后使用自膨式美敦力 CoreValve 系统的起搏器依赖情况。
Int J Cardiol. 2013 Sep 30;168(2):1269-73. doi: 10.1016/j.ijcard.2012.11.115. Epub 2013 Jan 5.
7
The impact of drug discontinuation in patients treated with temporary pacemaker due to atrioventricular block.因房室传导阻滞接受临时起搏器治疗的患者停用药物的影响。
J Cardiovasc Electrophysiol. 2013 Nov;24(11):1255-8. doi: 10.1111/jce.12211. Epub 2013 Jul 19.
8
Pacemaker memory in post-TAVI patients: Who should benefit from permanent pacemaker implantation?经导管主动脉瓣置换术(TAVI)后患者的起搏器记忆功能:谁应受益于永久性起搏器植入?
Pacing Clin Electrophysiol. 2018 Sep;41(9):1178-1184. doi: 10.1111/pace.13422. Epub 2018 Jul 16.
9
Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.经导管主动脉瓣置换术使用可重定位 LOTUS 装置后的传导异常和永久性起搏器植入:英国经验。
JACC Cardiovasc Interv. 2017 Jun 26;10(12):1247-1253. doi: 10.1016/j.jcin.2017.03.044.
10
Radiofrequency ablation of atrioventricular nodal reentrant tachycardia: the risk of intraprocedural, late and long-term atrioventricular block. The Veneto Region multicenter experience.房室结折返性心动过速的射频消融:术中、晚期及长期房室传导阻滞的风险。威尼托地区多中心经验。
Ital Heart J. 2002 Dec;3(12):715-20.

引用本文的文献

1
Beyond the Pain Management Clinic: The Role of AI-Integrated Remote Patient Monitoring in Chronic Disease Management - A Narrative Review.超越疼痛管理诊所:人工智能集成远程患者监测在慢性病管理中的作用——一项叙述性综述
J Pain Res. 2024 Dec 11;17:4223-4237. doi: 10.2147/JPR.S494238. eCollection 2024.

本文引用的文献

1
The need for permanent pacemaker after restoration of conduction following atrioventricular block: a retrospective cohort study.
Turk Kardiyol Dern Ars. 2020 Mar;48(2):103-108. doi: 10.5543/tkda.2019.96613.
2
Hyperkalemia in chronic kidney disease.慢性肾脏病中的高钾血症
Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s31-s36. doi: 10.1590/1806-9282.66.S1.31.
3
Hyperkalemia in patients with chronic renal failure.慢性肾衰竭患者的高钾血症。
Nephrol Dial Transplant. 2019 Dec 1;34(Suppl 3):iii12-iii18. doi: 10.1093/ndt/gfz231.
4
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2018年美国心脏病学会/美国心脏协会/心律学会关于心动过缓和心脏传导延迟患者评估与管理的指南:美国心脏病学会/美国心脏协会临床实践指南工作组及心律学会的报告
Circulation. 2019 Aug 20;140(8):e382-e482. doi: 10.1161/CIR.0000000000000628. Epub 2018 Nov 6.
5
Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes.估算肾小球滤过率降低与 2 型糖尿病患者心脏传导缺陷风险的相关性。
Diabetes Metab. 2018 Dec;44(6):473-481. doi: 10.1016/j.diabet.2018.08.007. Epub 2018 Sep 5.
6
Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis.心脏纤维化过程中转化生长因子-β(TGF-β)与WNT信号通路之间的相互作用。
Acta Biochim Pol. 2018;65(3):341-349. doi: 10.18388/abp.2018_2635. Epub 2018 Jul 24.
7
Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease.转化生长因子β受体抑制可预防进行性心脏传导疾病小鼠模型中的心室纤维化。
Cardiovasc Res. 2017 Apr 1;113(5):464-474. doi: 10.1093/cvr/cvx026.
8
Management of patients with drug-induced atrioventricular block.药物性房室传导阻滞患者的管理
Pacing Clin Electrophysiol. 2012 Jul;35(7):804-10. doi: 10.1111/j.1540-8159.2012.03410.x. Epub 2012 Apr 24.
9
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.药物性房室传导阻滞:停用致病药物后的预后
J Am Coll Cardiol. 2004 Jul 7;44(1):105-8. doi: 10.1016/j.jacc.2004.03.057.
10
Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs.β-肾上腺素受体阻断药的药代动力学特性比较
Eur Heart J. 1987 Dec;8 Suppl M:9-14. doi: 10.1093/eurheartj/8.suppl_m.9.